[Validity of a fixed atenolol/hydrochlorothiazide/amiloride combination (100/25/2.5 mg) in the therapy of essential arterial hypertension].
Salvadeo
A
A
Villa
G
G
Segagni
S
S
Moroni
G
G
Poggio
F
F
D000293:Adolescent; D000328:Adult; D000584:Amiloride / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D006852:Hydrochlorothiazide; D001262:Atenolol; D000584:Amiloride
Validità della associazione fissa atenololo/idroclorotiazide/amiloride (100/25/2.5 mg) nella terapia dell'ipertensione arteriosa essenziale.